U. Landmesser with M. Sabate and W. Wijns on EXAMINATION

submitted by: OxfordJournals

M. Sabate and W. Wijns in conversation with U. Landmesser on The Examination Trial
August 2011

European Heart Journal - My Cardio Interview: F. Ruschitza, H. Shimoni & F. Van de Werft on CREDO

submitted by: OxfordJournals

H. Shimoni and F. Van de Werft in conversation with F. Ruschitza:
CREDO- Kyoto PCI/CABG Registry Cohort 2

European Heart Journal - My Cardio Interview: Thomas Luscher & S. Windecker on Bern-Rotterdam

submitted by: OxfordJournals

S. Windecker in conversation with Thomas L&#252scher:
Bern-Rotterdam cohort

European Heart Journal - My Cardio Interview: T. Lüscher, T, Kimura & S. Windecker on RESET

submitted by: OxfordJournals

T. Kimura and S. Windecker in conversation with T. Lüscher:
The RESET Trial

European Heart Journal - My Cardio Interview: T. Lüscher, P. Sever & G. De Backe on ASCOT

submitted by: OxfordJournals

P. Sever and G. De Backe in conversation with T. Lüscher:
The ASCOT Trial

European Heart Journal - My Cardio Interview: Tom Lüscher, Marek Deja & Alec Vahanian on STICH

submitted by: OxfordJournals

Marek Deja and Alec Vahanian in conversation with Tom Lüscher:
The STICH trial

European Heart Journal - My Cardio Interview: Bill Abraham, M. Gold & C. Linde on SMART AV

submitted by: OxfordJournals

Bill Abraham in conversation with M. Gold & C. Linde:
SMART AV - QLV in LV reverse remodelling

European Heart Journal - My Cardio Interview: K. Fox & S. Hohnloser with U. Landmesser on ROCKET AF

submitted by: OxfordJournals

Ulf Landmesser in conversation with K. Fox & S. Hohnloser:
ROCKET AF - Rivaroxaban versus Warfarin in nonvalvular AF

European Heart Journal - My Cardio Interview: Chris Granger & Bernard Gersh on ARISTOTLE

submitted by: OxfordJournals

Chris Granger in conversation with Bernard Gersh:
ARISTOTLE trial - primary results

European Heart Journal - My Cardio Interview: Paolo Camici,Tom Lüscher & Keith Fox on VESSEL

submitted by: OxfordJournals

Tom Lüscher and Keith Fox in conversation with Paolo Camici:
dal - VESSEL - Dalcetrapib in CHD